Evidence map›Paper›PMID 26329556›Full record

ArticleBMC medical genetics2015

Insertion of an extra copy of Xq22.2 into 1p36 results in functional duplication of the PLP1 gene in a girl with classical Pelizaeus-Merzbacher disease.

Julien Masliah-Planchon, Céline Dupont, George Vartzelis, Aurélien Trimouille, Eléonore Eymard-Pierre, Mathilde Gay-Bellile, Florence Renaldo, Imen Dorboz, Cécile Pagan, Samuel Quentin and 6 more

Abstract readCase Reports
In one paragraph

Article in BMC medical genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Julien Masliah-PlanchonUF de Génétique moléculaire, Hôpital Robert Debré, AP-HP, Paris, France. julien.masliah@gmail.com.
Céline DupontUF de Cytogénétique, Hôpital Robert Debré, AP-HP, Paris, France. celine.dupont@jvr.aphp.fr.
George VartzelisPaediatric Neurology, P&A Kyriakou Paed. Hospital, Athens Medical School, Athens, Greece. vartzelis@gmail.com.
Aurélien TrimouilleUF de Génétique moléculaire, Hôpital Robert Debré, AP-HP, Paris, France. yayatrimouille@hotmail.com.
Eléonore Eymard-PierreCytogénétique Médicale, Univ Clermont1, UFR Médecine, CHU Estaing, Clermont-Ferrand, France. e_pierre@chu-clermontferrand.fr.
Mathilde Gay-BellileCytogénétique Médicale, Univ Clermont1, UFR Médecine, CHU Estaing, Clermont-Ferrand, France. mgay-bellile@chu-clermontferrand.fr.
Florence RenaldoInserm U1141, Université Paris Diderot, Sorbonne Paris Cité, Hôpital Robert Debré, Paris, France. florence.renaldo@rdb.aphp.fr.
Imen DorbozInserm U1141, Université Paris Diderot, Sorbonne Paris Cité, Hôpital Robert Debré, Paris, France. imen.dorboz@inserm.fr.
Cécile PaganUF de Génétique moléculaire, Hôpital Robert Debré, AP-HP, Paris, France. Cecile.pagan@chu-lyon.fr.
Samuel QuentinIUH, Hôpital Saint-Louis, Paris, France. samuel.quentin@sls.aphp.fr.
Monique ElmalehImagerie pédiatrique, Hôpital Robert Debré, AP-HP, Paris, France. monique.elmaleh@rdb.aphp.fr.
Christina KotsogianniPaediatric Neurology, P&A Kyriakou Paed. Hospital, Athens Medical School, Athens, Greece. christal_doc@yahoo.gr.
Elissavet KonstantelouPaediatric Neurology, P&A Kyriakou Paed. Hospital, Athens Medical School, Athens, Greece. eliskonst@yahoo.gr.
Séverine DrunatUF de Génétique moléculaire, Hôpital Robert Debré, AP-HP, Paris, France. severine.drunat@rdb.aphp.fr.
Anne-Claude TabetUF de Cytogénétique, Hôpital Robert Debré, AP-HP, Paris, France. anne-claude.tabet@rdb.aphp.fr.
Odile Boespflug-TanguyInserm U1141, Université Paris Diderot, Sorbonne Paris Cité, Hôpital Robert Debré, Paris, France. odile.boespflug-tanguy@rdb.aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPelizaeus-Merzbacher disease (PMD) is an X-linked dysmyelinating disorder characterized by nystagmus, hypotonia, ataxia, progressive spasticity, and cognitive decline. PMD classically results from a duplication of a genomic segment encompassing the entire PLP1 gene. Since the PLP1 gene is located in Xq22, PMD affects mostly boys. METHODS AND

resultsHere we report the case of a girl with typical PMD. Copy number analysis of the PLP1 locus revealed a duplication of the entire gene and FISH analysis showed that the extra copy of the PLP1 gene was actually inserted in chromosome 1p36. This insertion of an additional copy of PLP1 in an autosome led to a functional duplication irrespective of the X-inactivation pattern. Subsequent overexpression of PLP1 was the cause of the PMD phenotype observed in this girl. Further sequencing of the breakpoint junction revealed a microhomology and thus suggested a replication based mechanism (such as FoSTeS or MMBIR).

conclusionThis case emphasizes the susceptibility of the PLP1 locus to complex rearrangement likely driven by the Xq22 local genomic architecture. In addition, careful consideration should be given to girls with classical PMD clinical features since they usually experience complex PLP1 genomic alteration with a distinct risk of inheritance.

Indexed as

Chromosomes, Human, Pair 1FemaleGene DuplicationHumansIn Situ Hybridization, FluorescenceMagnetic Resonance ImagingMicroarray AnalysisMutagenesis, InsertionalMyelin Proteolipid ProteinPelizaeus-Merzbacher DiseaseX Chromosome InactivationMyelin Proteolipid ProteinPLP1 protein, human

Identifiers

PMID26329556
PMCPMC4557901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.